Mitch Levine
CEO & Chairman of the Board
Mitch Levine is a strategic-minded Chief Financial Officer, corporate finance innovator, and investment industry leader who has orchestrated mission-critical financial strategies to enhance corporate value and strengthen operating performance for public and private companies in the life sciences industry.
Read More
From 2017 to 2022, Mr. Levine was the Chief Financial Officer of Oncocyte (OCX: NasdaqGM) a molecular diagnostic company, where he oversaw corporate growth from eight employees to more than 120; conducted ten capital raises, bringing the company to fully-funded status; built the shareholder base from one institutional investor to more than 50; negotiated and integrated three acquisitions; and secured the largest licensing deal in company history with one of the largest and fastest-growing diagnostic laboratories in China.
From 2000 to 2017, Mr. Levine was Founder and Managing Member of Enable Capital Management, LLC, whose underlying investment vehicle, Enable Growth Partners, LP, was one of the most significant funds providing growth capital to small and mid-sized public and private companies.
Prior to Enable Capital Management, Mr. Levine was a Founding Member of the Shemano Group, a San Francisco-based investment bank focused on the capital needs of technology and life science companies where Mr. Levine was widely recognized for originating and developing one of the largest alternative financing markets in the US, generating more than $100 billion of financings annually.
Matthew Nunez
Matthew Nuñez has served as Chief Executive Officer of SMARTHealth Dx since 2019. Mr. Nuñez, an entrepreneur, has built businesses in diagnostic biomarker discovery, bioinformatics, advanced analytics, and precision medicine. Read MoreLarry Dentice
Larry Dentice is a highly regarded senior healthcare executive and a 35-year veteran of the diagnostics imaging field with proven expertise in engineering, service, manufacturing, marketing, sales, and business operations for several Fortune 500 companies Read MorePadma Sundar
Over fifteen years of experience leading and transforming organizations with disruptive diagnostic technologies to revenue-stage companies with market-leading tests. Six capital raises including three underwritten deals.Read MoreGus Blass III
Gus J. Blass III is an investment management professional with over 40 years of experience. Mr. Blass has served on the boards of directors for public, non-public, and non-profit organizations. Mr. Blass qualifies as an “audit committee financial expert” under Securities and Exchange Commission regulations.